Skip to main content
. 2016 Nov 22;16:914. doi: 10.1186/s12885-016-2945-2

Table 2.

Adverse events from mTMZ that were tabulated during the study period

Adverse events Severity number of patients (%)
Grade 1 & 2 Grade 3 & 4
Hematological
 Anemia 1 (11%) 0
 Leukopenia 2 (22%) 0
 Lymphopenia 2 (22%) 0
 Neutropenia 1 (11%) 0
 Thrombocytopenia 1 (11%) 0
 Fatigue 1 (11%) 0
Gastrointestinal
 Increased alkaline phosphatase 0 0
 Increased ALT 1 (11%) 1 (11%)
 Increased AST 1 ( 11%) 0
Infection
 Thrush 1 (11%) 0
 Zoster eruption 1 (11%) 0
Skin
 Petechial rash 1 (11%) 0